DL

Dhana Lakshmi Tirupathi

Active Director Director DIN 07167886
DIN 07167886 First appointment Apr 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Dhana Lakshmi Tirupathi

Data last updated:

Dhana Lakshmi Tirupathi is a Director at Averx Drugs Private Limited (since 2015). The company operates in Pharma. Averx Drugs Private Limited reported revenue of ₹6.36 Cr (FY 2021).

DIN 07167886
Primary Designation Director
Industry Pharma
First Appointment 25 Apr 2015
Oldest Company Age 12 yrs
Largest company Averx Drugs Private Limited · ₹6.36 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Averx Drugs Private Limited U24100AP2014PTC095163
Director25 Apr 20152014₹6.36 Cr (FY 2021)Active

Board colleagues of Dhana Lakshmi Tirupathi

Directorship timeline

Open interactive timeline →
Averx Drugs Private Limited
Premium access

Shareholding and investment profile for Dhana Lakshmi Tirupathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhana Lakshmi Tirupathi

Dhana Lakshmi Tirupathi currently holds 1 directorship: Averx Drugs Private Limited (Director, since 25 Apr 2015, revenue ₹6.36 Cr (FY 2021)).

Dhana Lakshmi Tirupathi was first appointed on 25 Apr 2015 as Director at Averx Drugs Private Limited.

The current boards of Dhana Lakshmi Tirupathi's companies include Nagasekhar Ramineni (Averx Drugs Private Limited), Srinivas Ramineni (Averx Drugs Private Limited), Vns Gopal Raju Kurapati (Averx Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available